On July 31, 2025, the Health Resources and Services Administration (HRSA), Office of Pharmacy Affairs (OPA) issued a 340B Drug Pricing Program notice (the “Notice”) announcing the launch of a ...
The hospital lobby is asking federal officials to head off expanded data collection policies some drugmakers are implementing ...
The Trump administration is pushing significant changes to the healthcare status quo that it says will save money, improve oversight and make the $4.9 trillion sector more efficient. Many of the HHS’ ...
The 340B program stands at a critical crossroads in 2026. With the recent court-ordered pause of the rebate pilot program and HHS’s decision to “go back to the drawing board,” covered entities have ...
As we look ahead to 2026, the operational demands on 340B programs are increasing across every dimension. Between the implementation of the 340B Rebate Model pilot and Maximum Fair Price (MFP) covered ...
On December 29, 2025—just three days before the 340B Rebate Model Pilot Program (the Rebate Program) was set to begin—the U.S. District Court for the District of Maine issued an order granting a ...
AHA letter to the Health Resources and Services Administration about a new concerning development with the 340B Program.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results